Diagnosis and Clinical Management of Chronic Graft-versus-Host Disease

International Journal of Hematology

Volumn 79, Issue 3, 2004, Pages 221-228

  Martin, Paul J ^a,b   Carpenter, Paul A ^a   Sanders, Jean E ^a   Flowers, Mary E D ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b F Hutchinson Cancer Res C D2 100   (United States)

Author keywords

Chronic graft versus host disease; Hematopoietic cell transplantation; Immunosuppression; Late effects

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CALCINEURIN INHIBITOR; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; CEVIMELINE; CYCLOSPORIN A; DILTIAZEM; ERYTHROMYCIN; FLUCONAZOLE; GLUCOCORTICOID; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; ITRACONAZOLE; KETOCONAZOLE; NICARDIPINE; NIFEDIPINE; PILOCARPINE; PREDNISONE; TACROLIMUS; TRIAZOLE DERIVATIVE; UNINDEXED DRUG; URSODEOXYCHOLIC ACID; VALACICLOVIR; VERAPAMIL; VITAMIN D; VORICONAZOLE;

ADRENAL INSUFFICIENCY; ALLOGENIC BONE MARROW TRANSPLANTATION; ANTIBIOTIC PROPHYLAXIS; AVASCULAR NECROSIS; CATARACT; CLINICAL TRIAL; DISABILITY; GLUCOSE INTOLERANCE; GRAFT VERSUS HOST REACTION; GROWTH RETARDATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; MENTAL INSTABILITY; MORBIDITY; MORTALITY; OSTEOPOROSIS; PATHOGENESIS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; REVIEW; RISK FACTOR; SIDE EFFECT; SKIN ATROPHY; SLEEP DISORDER; STEROID THERAPY; STRIA; WEIGHT GAIN;

EID: 2442624727     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.03176     Document Type: Review

References (21)

1. Sullivan KM. Graft-versus-host disease. In: Thomas ED, Blume KG, Forman SJ, eds. Hematopoietic Cell Transplantation. 2nd ed. Malden, Mass: Blackwell Science; 1999:515-536.
2. Socié G, Stone JV, Wingard JR, et al. Long-term survival and late deaths after allogeneic bone marrow transplantation. N Engl J Med. 1999;341:14-21.
3. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man: a long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204-217.
4. Antin J. Clinical practice: long-term care after hematopoietic-cell transplantation in adults. N Engl J Med. 2002;347:36-42.
5. Vogelsang GB. How I treat chronic graft-versus-host disease. Blood. 2001;97:1196-1201.
6. Lee SJ, Vogelsang G, Flowers MED. Chronic graft-versus-host disease. Biol Blood Marrow Transplant. 2003;9:215-233.
7. Mielcarek M, Martin PJ, Leisenring W, et al. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood. 2003;102:756-762.
8. Sullivan KM, Witherspoon RP, Storb R, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-versus-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood. 1988;72:546-554.
9. Wingard JR, Piantadosi S, Vogelsang GB. Predictors of death from chronic graft-versus-host disease after bone marrow transplantation. Blood. 1989;74:1428-1435.
10. Akpek G, Zahurak ML, Piantadosi S, et al. Development of a prognostic model for grading chronic graft-versus-host disease. Blood. 2001;97:1219-1226.
11. Sullivan KM, Shulman HM, Storb R, et al. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood. 1981;57:267-276.
12. Cooper MS, Stewart PM. Corticosteroid insufficiency in acutely ill patients. N Engl J Med. 2003;348:727-734.
13. Axelrod L. Glucocorticoid therapy. Medicine (Baltimore). 1976; 55:39-65.
14. Sullivan KM, Witherspoon RP, Storb R, et al. Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-versus-host disease. Blood. 1988;72:555-561.
15. Koc S, Leisenring W, Flowers MED, et al. Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone. Blood. 2002;100: 48-51.
16. Flowers MED, Lee S, Vogelsang G. An update on how to treat chronic GVHD. Blood. 2003;102:2312.
17. Boeckh M, Leisenring W, Riddell SR, et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood. 2003;101:407-414.
18. Marr KA, Carter RA, Boeckh M, Martin P, Corey L. Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood. 2002;100:4358-4366.
19. Rosenthal P, Cotter J. The Boston Scleral Lens in the management of severe ocular surface disease. Ophthalmol Clin North Am. 2003; 16:89-93.
20. Flowers MED. Traditional treatment of chronic graft-versus-host disease. Blood Marrow Transplant Rev. 2002;12:5-8.
21. Flowers MED, Parker PM, Johnston LJ, et al. Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial. Blood. 2002;100:415-419.